Where is the live CopyMark page for USPTO serial 75071007?

The live record is at https://getcopymark.com/trademark/75071007. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns TARGETING CANCER WITH THE HUMAN IMMUNE SYSTEM?

According to the public USPTO record for serial number 75071007, the listed owner(s) include: NOVOPHARM LIMITED.

What is USPTO serial number 75071007?

Serial number 75071007 is the USPTO application identifier for the mark TARGETING CANCER WITH THE HUMAN IMMUNE SYSTEM. It is used to track examination, publication, and registration of this trademark.

What is the current status of TARGETING CANCER WITH THE HUMAN IMMUNE SYSTEM?

TARGETING CANCER WITH THE HUMAN IMMUNE SYSTEM (75071007) currently shows USPTO status code 601 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover TARGETING CANCER WITH THE HUMAN IMMUNE SYSTEM?

The public record lists International Classes: 005, 016, 042. Each class corresponds to categories of goods or services identified in the application or registration.

4.9/5

USPTO serial 75071007

TARGETING CANCER WITH THE HUMAN IMMUNE SYSTEM

Reviewed by CopyMark Law Group

Status 601

Filing date: Mar 12, 1996
Status date: Oct 21, 1996
Registration date: —
Examiner: TRIPI, CYNTHIA
Law office: FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with TARGETING CANCER WITH THE HUMAN IMMUNE SYSTEM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

NOVOPHARM LIMITED
Scarborough, Ontario, CA
Other trademarks owned by NOVOPHARM LIMITED

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

BRUCE L. ADAMS

BRUCE L ADAMS ADAMS & WILKS50 BROADWAY 31ST FLNEW YORK, NY 10004UNITED STATES

Goods and services

Class	Description	Status	First use
005	pharmaceutical preparations	ABANDONED	—
016	printed publications, namely periodicals, brochures, pamphlets, magazines and newsletters	ABANDONED	—
042	biotechnology research and development	ABANDONED	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Oct 21, 1996	ABN1	ABANDONMENT - EXPRESS MAILED	—
Sep 3, 1996	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Aug 24, 1996	CNRT	NON-FINAL ACTION MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 15, 1996	DOCK	ASSIGNED TO EXAMINER	—